Jon M. Foster - May 15, 2024 Form 4 Insider Report for HCA Healthcare, Inc. (HCA)

Role
EVP and COO
Signature
/s/ Natalie Harrison Cline, Attorney-in-Fact
Stock symbol
HCA
Transactions as of
May 15, 2024
Transactions value $
-$3,519,394
Form type
4
Date filed
11/18/2024, 05:47 PM
Previous filing
Feb 21, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HCA Common Stock Gift $0 -5.35K -100% $0.00 0 May 15, 2024 By Spouse
transaction HCA Common Stock Gift $0 +5.35K +10.93% $0.00 54.3K May 15, 2024 By LCF Trust (Reporting Person, Trustee)
transaction HCA Common Stock Other -$3.35M -9.5K -23.73% $352.74 30.5K Nov 14, 2024 Direct F1
transaction HCA Common Stock Other $3.35M +9.5K +17.26% $352.74 64.6K Nov 14, 2024 By JMF Trust (Spouse and Robert Nagel, Co-Trustees) F1
transaction HCA Common Stock Gift $0 -1.96K -6.4% $0.00 28.6K Nov 14, 2024 Direct
transaction HCA Common Stock Gift $0 +1.96K +3.03% $0.00 66.5K Nov 14, 2024 By JMF Trust (Spouse and Robert Nagel, Co-Trustees)
transaction HCA Common Stock Gift $0 -18K -62.98% $0.00 10.6K Nov 14, 2024 Direct
transaction HCA Common Stock Gift $0 +18K $0.00 18K Nov 14, 2024 By Spouse
transaction HCA Common Stock Options Exercise $3.7M +36.6K +345.94% $101.16 47.2K Nov 14, 2024 Direct
transaction HCA Common Stock Tax liability -$7.22M -20.9K -44.3% $345.51 26.3K Nov 14, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HCA Stock Appreciation Right Options Exercise $0 -36.6K -100% $0.00 0 Nov 14, 2024 Common Stock 36.6K $101.16 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Pursuant to a power of substitution, on November 14, 2024, the Reporting Person transferred 9,502 shares of common stock of the Issuer to a trust in exchange for assets of equal value. The transfer was made at a price per share equal to $352.74 (the average of the high and low prices of shares of common stock of the Issuer on November 14, 2024). The transfer did not change the total number of shares of common stock of the Issuer of which the Reporting Person may be deemed to have beneficial ownership.
F2 The stock appreciation rights vested in four equal annual installments beginning on January 31, 2019.